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Objective
The treatment of early-stage colorectal cancers removed endoscopically depends on histopathologic findings. The aim of this 
retrospective study was to assess the benefit–risk balance for patients who underwent colectomy after endoscopic polypec-
tomy of a T1 carcinoma with unfavourable histological factors.
Methods 
From January 1st 2004 to February 28th 2014, twenty-three patients (12 men and 11 women, age median 66 years) who 
underwent colectomy after endoscopic resection of malignant polyps with T1 carcinoma were included in this retrospec-
tive study. Specimens resected after endoscopic polypectomy showed at least one of the two unfavorable factors – no free 
margin or piecemeal resection. The main objective was to assess the benefit–risk balance of oncological resection performed 
after polypectomy. The oncological benefit was measured by the lymph node metastasis rate, and the risk was measured by 
the occurrence of severe (grade III–IV) complications or death.
Results 
The most common localisation of T1 cancer was the sigmoid colon (10 cases, 43.5%) and the upper rectum (9 cases, 39.1%). 
Nine (39.1%) patients had a well-differentiated adenocarcinoma (G1), while others (14 patients from 23, 60.9%) had a moder-
ately differentiated adenocarcinoma (G2). The main indications for colectomy were the margin of resection ≤ 1 mm (n = 17) 
and peacemeal resection (n = 7). The most common surgical operation was rectal resection with partial mesorectal excision 
(9, 39.1%). The oncological benefit of colectomy was reached for two patients (8.7%) who had lymph node metastases. Five 
patients (21.7%) presented postoperative complications. These complications did not rise surgery risk, because all of them 
were of I–II grade according to Clavien’s classification. There were no deaths.
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Conclusions
Among the patients who underwent oncological colectomy after endoscopic polypectomy for unexpected polypoid T1 can-
cer with unfavorable histology (no free margin or peacemeal polypectomy) 8.7% had metastases in the lymph nodes; thus, 
this study suggests the rationale of oncological surgical resection after endoscopic polypectomy for these patients.
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Tikslas 
Ankstyvos stadijos storosios ir tiesiosios žarnos vėžio, pašalinto endoskopiniu būdu, tolesnė gydymo taktika priklauso nuo 
histologinio ištyrimo radinių. Šio tyrimo tikslas yra įvertinti kolektomijos naudos ir rizikos santykį pacientams, kuriems atlikta 
endoskopinė polipektomija ir histologinio tyrimo metu rasti nepalankūs histologiniai veiksniai. 
Metodika
Į šį retrospektyvųjį tyrimą įtraukta 23 pacientai (12 vyrų ir 11 moterų, amžiaus mediana 66 metai), kuriems nuo 2004 m. sausio 
1 d. iki 2014 m. vasario 28 d. VUOI buvo atlikta kolektomija po kolonoskopinės piktybinių polipų su T1 vėžiu polipektomijos dėl 
bent vieno iš šių nepalankių histologinių veiksnių: teigiamas rezekcijos kraštas ar polipas pašalintas dalimis. Pagrindinis tiks-
las buvo įvertinti onkologinės kolektomijos, atliktos po endoskopinės polipektomijos, naudos ir rizikos santykį. Onkologinė 
nauda vertinta pagal pacientų, kuriems rasta metastazių limfmazgiuose, skaičių. Rizika vertinta atsižvelgiant į III–IV laipsnio 
komplikacijų dažnį ir mirtingumą.
Rezultatai 
Dažniausia piktybinių polipų su T1 vėžiu vieta buvo riestinė žarna – 10 atvejų (43,5 %) ir viršutinis tiesiosios žarnos trečdalis – 
9 atvejai (39,1 %). Devyniems (39,1 %) pacientams histologinio tyrimo metu rasta geros diferenciacijos adenokarcinoma (G1), 
kitiems (14 pacientų iš 23, 60,9 %) – vidutinės diferenciacijos adenokarcinoma (G2). Pagrindinės kolektomijos indikacijos buvo 
dvi: rezekcijos kraštas ≤1 mm (n=17), rezekcija dalimis (n=7). Daugiausia buvo atlikta tiesiosios žarnos rezekcijų su daline me-
zorektine ekscizija – 9 (39,1 %). Onkologinė kolektomijos nauda pasiekta dviem pacientams (8,7 %), kurie turėjo metastazių 
limfmazgiuose. Penkiems pacientams (21,7 %) pasireiškė pooperacinių komplikacijų. Šios komplikacijos nedidino operacinės 
rizikos, nes pagal Clavien klasifikaciją buvo I–II laipsnio. Mirties atvejų nepasitaikė. 
Išvada
Atliktus onkologinę kolektomiją dėl nepalankių histologinių veiksnių (teigiamas rezekcijos kraštas ar rezekcija dalimis) po 
endoskopinės polipektomijos, 8,7 % pacientų rasta metastazių limfmazgiuose, todėl šis retrospektyvusis tyrimas pabrėžia 
onkologinės rezekcijos svarbą šių pacientų grupėje. 
Reikšminiai žodžiai: piktybinis tiesiosios žarnos polipas, endoskopinė polipektomija, limfmazgių metastazės
Introduction
Malignant colonic polyp is defined as an endoscopically 
removed adenomatous polyp in which cancer cells occur 
in submucosal lesions [1, 2]. The prevalence of malignant 
polyps in the series of endoscopically removed polyps 
is between 0.2% and 11% [3]. This is set to rise with 
increased numbers being identified in the bowel cancer 
screening programme. Consequently, a clear treatment 
algorithm is needed to treat patients correctly and safely. 
There have been various therapeutic options concern-
ing treatment strategy after endoscopic removal of a 
malignant polyp, ranging from a conservative approach 
to colectomy with an extensive lymph node dissection. 
A radical bowel resection is indicated in cases of 
inadequate excision, i.e. absence of malignant cells 
1–2 mm from the transsected margin, or if the histology 
reveals undifferentiated adenocarcinoma [3, 4]. When 
polyps are removed using the piecemeal technique, it 
is impossible to assess the depth of infiltration and 
the margin of these polyps [3–5], on which the further 
treatment may also be based. Despite the use of these 
unfavorable histological criteria to select patients for 
operating, many procedures are unnecessary and are 
sometimes followed by serious complications. The risk 
of local recurrence and lymph node metastases must 
also be compared with that of morbidity and mortality 
following surgery. The number of cases in which high 
risk is associated with surgical procedures under general 
anesthesia has increased due to the increased numbers of 
elderly cases and cases with concurrent diseases. 
Therefore, we have conducted this retrospective study 
to evaluate the oncological benefit (measured by the 
rate of lymph node metastases and the persistence of 
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residual adenocarcinoma) of an additional colectomy af-
ter the initial endoscopic polypectomy for T1 colorectal 
cancer. The morbidity was also analyzed in order to assess 
the risk–benefit balance of this procedure.
Materials and methods
Data were collected retrospectively from January 1st 
2004 to February 28th 2014 on all twenty-three 
patients who underwent additional colectomy after a 
radical endoscopic removal of malignant polyps with 
T1 carcinoma at the Vilnius University Oncology 
Institute. Resection was done based on at least one 
of the two unfavorable histological criteria – no free 
margin or piecemeal resection. All patients gave their 
signed informed consent. No patient had received any 
neoadjuvant treatment before surgery.
The technique of polypectomy is standardized and 
has been described elsewhere [6]. The majority of 
large sessile polyps were resected using the piecemeal 
technique.
All patients underwent elective oncological surgery, 
including the resection of the concerned segment and 
regional lymphadenectomy. Accurate localization of 
the polyp was achieved with a metallic clip, endo-
scopic tattooing, or intraoperative colonoscopy, but it 
was not systematic. The procedures were performed by 
laparotomy or laparoscopy, depending on the surgeon’s 
preferences and the patient’s surgical history. The pri-
ciples of the extent of open and laparoscopic resections 
were the same.   
Resected specimens were placed into a sample bottle 
and fixed in 10% buffered formaline for 12–48 h. Surgi-
cal specimens were examined by experienced patholo-
gists, and these data were analyzed retrospectively.
The primary end point was to assess the detailed 
oncologic features of T1 colorectal cancer, removed 
endoscopically, with unfavorable histological criteria 
which indicated a need for additional surgery. To this 
end, a response variable was considered linking the pres-
ence of positive lymph nodes and the insufciency of the 
endoscopic excision with the persistence of a residual 
adenocarcinoma on the specimen.
Table 1. Baseline characteristics of patients
Number of patients N = 23
Age (years)
  Median 66 (46–73)
  ≥ 66 52.2% (12)
Gender
  Male 52.2% (12)
  Female 47.8% (11)
American Society of Anaesthesiologists class
1 4.3% (1)
2 60.9% (14)
3 30.4% (7)
4 4.3% (1)
Table 2. Clinical and morphological characteristics of patients
Differentiation grade
  Well differentiated adeno-
carcinoma (G1)
39.1% (9/23)
  Moderately differentiated 
adenocarcinoma (G2)
60.9% (14/23)
Resection
  Laparoscopic 43.5% (10)
  Open 56.5% (13)
Procedure
  Left hemicolectomy 21.7% (5)
  Right hemicolectomy 13.0% (3)
  Sigmoid resection 21.7% (5)
  Resection of transverse 
colon
4.3% (1)
  Rectal resection with parti-
al mesorectal excision
39.1% (9)
Polyp size (mm)
  Mean 16.5 [5–40]
Indications for additional 
colectomy
  Margin ≤ 1mm 73.9% (17)
  Peacemeal resection 30.4% (7)
Total sampling node
  Median 8 [0–39]
   ≥ 8 52.2% (12)
Lymph node metastases 8.7% (2)
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Another objective was to analyze short-term complica-
tions of additional surgery. Mortality and morbidity were 
defined respectively as death or complications occur-
ring following surgery during the hospital stay. Comp - 
lications were classified in accordance with Clavien’s 
classification [7]. Finally, we assessed the benefit–risk 
balance of this procedure, with the assumption that the 
short-term risk assessed by the severe complications of 
grade 3–4 or death was as serious as the long-term risk 
measured by the presence of positive lymph nodes or 
residual adenocarcinoma on the specimen.
Results
Twenty-three patients [12 males; median age at surgery 
66 years (range, 46–73)] were included in the present 
study. Patient demographics are shown in Table 1. Most 
patients were of American Society of Anaesthesiologists 
(ASA) class 2. The minority of patients were of ASA 
classes 1 and 4. The most common localisation of T1 
cancer was sigmoid colon (10 cases, 43.5%) and rectum 
(9 cases, 39.1%), others (transverse colon, hepatic flex-
ure, ascending colon, caecum) – 4.3% each.The average 
polyp size was 16,5 (range, 5–40) mm. The majority of 
colorectal polyps were left-sided in location: 82.6% were 
sited at or distal to the splenic flexure (Figure 1). Clini-
copathologic features with adverse histological criteria 
that led to surgery and the surgical procedures are de-
tailed in Table 2. There were no distant metastases found 
in any of the patients, either intraoperatively or by 
radiological imaging. The median number of retrieved 
lymph nodes per patient was 8 (range, 0– 39). In two 
patients (8.7 %) who had lymph node metastases, pol-
yps were localised in the upper rectum and the sigmoid 
colon. Their clinicomorphological features are shown in 
Table 4. No one had residual adenocarcinomas. 
Overall complication was identified in 5 (21.7 %) 
of the 23 patients. Complications are summarized in 
Table 3. There were no severe complications of grade 
III–IV or surgical mortalities. The median length of 
hospital stay was 12 days (range, 5–22).
Discussion
In our study, 8.7% of patients had lymph node me-
tastases, and no one had residual adenocarcinoma on 
Figure 1. Location of colorectal polyps. Asc, ascending colon; Caec, caecum; 
Hep, hepatic flexure; Sig, sigmoid; Upper rect, upper rectum; Tran, Transverse 
colon
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Table 3. Postoperative complications in 23 patients 
Postoperative outcomes Number of patients (%)
Dindo–Clavien grade II 
complications
5 (21.7)
Pneumonia 1 (4.3)
Hypovolemic shock 1 (4.3)
Postoperative ileus 1 (4.3)
Urinary infection 1 (4.3)
Wound infection 1 (4.3)
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the specimen, although we selected patients whose pol-
ypectomy was considered complete by the endoscopist 
and adenocarcinoma was incidentally found in a histo-
pathological examination with no free margin or after 
polypectomy using the piecemeal technique. However, 
to claim a complete endoscopic removal requires expe-
rience with polypectomy [8]. The absence of remnant 
cancer could be explained by the fact that coagulation 
artefacts of snare polypectomy make it difcult for the 
pathologist to confirm tumour-free margins [5]. Moreover, 
our study design contributed to the low rate of residual tu-
mours, since only macroscopically benign looking polyps 
revealing malignancy at histology were included in this 
study. Furthemore, it could be hard to reconstruct polyp’s 
anatomy on histopathological examination after polypec-
tomy using the piecemeal technique [9]. Accordingly, the 
aim of this study was to assess oncological benefit of 
additional colectomy in these cases. 
Our sample size is moderate, but it included highly-
selected patients. For patients with T1 colorectal cancer, 
the lymph node metastasis rate varies from 6 to 8% 
[10]. In our study, 8.7% of patients had lymph node 
metastases, which is the upper limit of the rate usually 
reported in the literature. According to the current lit-
erature, incomplete or doubtfully complete resection, 
poor differentiation and lymphovascular invasion are 
the main risk factors for positive lymph nodes [3–5, 
11]. Additional surgery is required for patients who 
present multiple adverse histological criteria. If only one 
criterion is selected, the indication should be discussed, 
especially for patients with multiple comorbidities [12]. 
Most authors claim that a clear resection margin is any-
where from 1 mm [13] (as this definition was used in 
our study) to 2 mm [2, 14]. According to Naqvi et al., 
even those with a <1mm clearance of cancer cells can be 
treated with surveillance [15].
There is also a debate about the number of lymph 
nodes which should be examined for an adequate 
staging of colorectal cancer. The guidelines 2000 for 
colon and rectal cancer surgery, published by the 
National Cancer Institute in the USA, recommend 
that 12  lymph nodes should be examined [16]. Nev-
ertheless, these results are based on data collected from 
T3 and T4 tumors. According to Benhaim et al., the 
number of lymph nodes is not a reliable indicator 
of the quality of surgery or of the histopathological 
examination when colectomy is done for malignant 
polyps removed endoscopically [17]. Maggard et al. 
have reported that the examination of ≥4 lymph nodes 
is enough for staging the T1 cancer. With a median of 
eight lymph nodes examined per specimen, our results 
are consistent with the literature [18].
According to Fielding et al. [19], up to 12% of pa-
tients older than 70 years die during or after a curative 
resection of colon cancer. They also claim that the risk 
of local recurrence or persisting lymph node metastases 
might be acceptable in these patients [19]. In our study, 
the median age of patients was 66 years, and we had no 
deaths. Technical advances during the last two decades, 
such as more developed laparoscopic surgery, could have 
a positive influence on the mortality of the elderly. 
Of the patients operated on, 21.7% presented just grade 
II complications. The current literature shows that surgery 
for colorectal cancer is still marked by a mortality of 2 to 
5% and the overall morbidity approaching 30% [20].
Of course, this study has some drawbacks, since it is 
a retrospective study with a moderate sample size. This 
study did not focus on long-term oncological results. 
Table 4. Clinicomorphological features of patients with lymph node matastases 
Patient Age Sex ASA Hosp. days
No free 
margin
Peace-
meal Loc. Diff.
Diame-
ter (mm)
Positive 
lymph 
nodes
1 72 F 3 13 + + Upper 
rectum
G2 20 1/13
2 51 F 2 10 + - Sigmoid G2 40 1/16
F – female; ASA – American Society of Anaestesiologists class; Hosp. – hospitalization; Loc. – localization; Dif. – differentia-
tion; G2 – moderate differentiation.
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However, the risk of recurrence in patients without 
lymph node metastases or residual adenocarcinoma on 
the specimen is exceptional. Many studies have clarified 
that an unfavorable histologic grade, such as poorly dif-
ferentiated or mucinous adenocarcinoma, is a risk factor 
for lymph node metastases in colorectal cancer [13, 21], 
but we had no patient with such factors in this study, 
because their incidence is usually lower than 5% [22]. A 
multicentric prospective study could provide additional 
results, in particular to weigh each adverse histologi-
cal criterion. Despite these limitations, our patients 
were included consecutively, and the population was 
perfectly homogeneous with the strict inclusion criteria. 
We, therefore, believe that these results reflect the reality.
Conclusions
Of the patients who underwent oncological colectomy 
after endoscopic polypectomy for unexpected polypoid 
T1 cancer with unfavorable histology (no free margin 
or peacemeal polypectomy) 8.7% had metastases in the 
lymph nodes. Thus, this study underlines the rationale 
of oncological surgical resection after endoscopic polyp-
ectomy for these patients.
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